Cargando…

Aberrant Expression of Citrate Synthase is Linked to Disease Progression and Clinical Outcome in Prostate Cancer

PURPOSE: Citrate synthase (CS) is a rate-limiting enzyme in the citrate cycle and is capable of catalyzing oxaloacetate and acetyl-CoA to citrate. CS has been uncovered to be upregulated in a variety of cancers, and its expression and clinical significance in prostate cancer (PCa) remain unknown. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Zhiduan, Deng, Yulin, Ye, Jianheng, Zhuo, Yangjia, Liu, Zezhen, Liang, Yingke, Zhang, Hui, Zhu, Xuejin, Luo, Yong, Feng, Yuanfa, Liu, Ren, Chen, Guo, Wu, Yongding, Han, Zhaodong, Liang, Yuxiang, Jiang, Funeng, Zhong, Weide
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7398875/ https://www.ncbi.nlm.nih.gov/pubmed/32801864 http://dx.doi.org/10.2147/CMAR.S255817

Ejemplares similares

Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

Metformin escape in prostate cancer by activating the PTGR1 transcriptional program through a novel super-enhancer
por: Ye, Jianheng, et al.
Publicado: (2023)

A HIF1α-GPD1 feedforward loop inhibits the progression of renal clear cell carcinoma via mitochondrial function and lipid metabolism
por: Liu, Ren, et al.
Publicado: (2021)

Integrated analysis reveals prognostic value and progression-related role of AMIGO2 in prostate cancer
por: Han, Zhaodong, et al.
Publicado: (2022)

Down-regulation of ACACA suppresses the malignant progression of Prostate Cancer through inhibiting mitochondrial potential
por: Zhang, Hui, et al.
Publicado: (2021)

The ALDOA Metabolism Pathway as a Potential Target for Regulation of Prostate Cancer Proliferation
por: Kuang, Qiwen, et al.
Publicado: (2021)

Identification and Validation of a PPP1R12A-Related Five-Gene Signature Associated With Metabolism to Predict the Prognosis of Patients With Prostate Cancer
por: Zou, Zhihao, et al.
Publicado: (2021)

Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer
por: Chen, Chaojiang, et al.
Publicado: (2020)

The prognostic roles of CYP19A1 expression in bladder cancer patients of different genders
por: Cai, Shanghua, et al.
Publicado: (2021)

TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
por: Zhu, Xuejin, et al.
Publicado: (2021)

Corrigendum: TFEB Promotes Prostate Cancer Progression via Regulating ABCA2-Dependent Lysosomal Biogenesis
por: Zhu, Xuejin, et al.
Publicado: (2021)

Carbon Nanospheres Exert Antitumor Effects Associated with Downregulation of 4E-BP1 Expression on Prostate Cancer
por: Dong, Weimin, et al.
Publicado: (2020)

Prediction of Biochemical Recurrence-Free Survival of Prostate Cancer Patients Leveraging Multiple Gene Expression Profiles in Tumor Microenvironment
por: Zhou, Rui, et al.
Publicado: (2021)

Acetyl-CoA carboxylase 1 depletion suppresses de novo fatty acid synthesis and mitochondrial β-oxidation in castration-resistant prostate cancer cells
por: Liu, Shaoyou, et al.
Publicado: (2022)

Offsetting Expression Profiles of Prognostic Markers in Prostate Tumor vs. Its Microenvironment
por: Jia, Zhenyu, et al.
Publicado: (2019)

Prognostic implication of heterogeneity and trajectory progression induced by enzalutamide in prostate cancer
por: Feng, Yuanfa, et al.
Publicado: (2023)

Disulfiram‐copper activates chloride currents and induces apoptosis with tyrosine kinase in prostate cancer cells
por: Lei, Wei, et al.
Publicado: (2021)

Citrate synthase from Synechocystis is a distinct class of bacterial citrate synthase
por: Ito, Shoki, et al.
Publicado: (2019)

Integrated high-throughput analysis identifies super enhancers in metastatic castration-resistant prostate cancer
por: Zeng, Jie, et al.
Publicado: (2023)

Identification and experimental validation of a tumor-infiltrating lymphocytes–related long noncoding RNA signature for prognosis of clear cell renal cell carcinoma
por: Deng, Yulin, et al.
Publicado: (2022)

Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies
por: Tan, Xiao, et al.
Publicado: (2023)

Characterization of the m6A-Associated Tumor Immune Microenvironment in Prostate Cancer to Aid Immunotherapy
por: Liu, Zezhen, et al.
Publicado: (2021)

Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer
por: Ye, Jianheng, et al.
Publicado: (2018)

Allosteric role of the citrate synthase homology domain of ATP citrate lyase
por: Wei, Xuepeng, et al.
Publicado: (2023)

The Novel Role of Mitochondrial Citrate Synthase and Citrate in the Pathophysiology of Alzheimer’s Disease
por: Chhimpa, Neeraj, et al.
Publicado: (2023)

Loss of the respiratory enzyme citrate synthase directly links the Warburg effect to tumor malignancy
por: Lin, Chin-Chih, et al.
Publicado: (2012)

Association between allergic conditions and risk of prostate cancer: A Prisma-Compliant Systematic Review and Meta-Analysis
por: Zhu, Jianguo, et al.
Publicado: (2016)

Identification of a novel microRNA-mRNA regulatory biomodule in human prostate cancer
por: Zhang, Yanqiong, et al.
Publicado: (2018)

MYPT1 inhibits the metastasis of renal clear cell carcinoma via the MAPK8/N‐cadherin pathway
por: Xie, Qingling, et al.
Publicado: (2022)

Apoferritin is maintaining the native conformation of citrate synthase in vitro
por: Sergeev, Yuri V, et al.
Publicado: (2018)

Citrate Synthase and OGDH as Potential Biomarkers of Atherosclerosis under Chronic Stress
por: Meng, Ling-bing, et al.
Publicado: (2021)

Low Citrate Synthase Activity Is Associated with Glucose Intolerance and Lipotoxicity
por: Alhindi, Yosra, et al.
Publicado: (2019)

Mitochondrion-associated protein peroxiredoxin 3 promotes benign prostatic hyperplasia through autophagy suppression and pyroptosis activation
por: Jiang, Min-Yao, et al.
Publicado: (2017)

Detailed Enzyme Kinetics in Terms of Biochemical Species: Study of Citrate Synthase
por: Beard, Daniel A., et al.
Publicado: (2008)

Obesity Affects Mitochondrial Citrate Synthase in Human Omental Adipose Tissue
por: Christe, Martine, et al.
Publicado: (2013)

Corrigendum to “Low Citrate Synthase Activity Is Associated with Glucose Intolerance and Lipotoxicity”
por: Alhindi, Yosra, et al.
Publicado: (2019)

Human METTL12 is a mitochondrial methyltransferase that modifies citrate synthase
por: Rhein, Virginie F., et al.
Publicado: (2017)

Bacterial cell cycle control by citrate synthase independent of enzymatic activity
por: Bergé, Matthieu, et al.
Publicado: (2020)

Citrate Synthase Expression Affects Tumor Phenotype and Drug Resistance in Human Ovarian Carcinoma
por: Chen, Lilan, et al.
Publicado: (2014)

Effect of downregulated citrate synthase on oxidative phosphorylation signaling pathway in HEI-OC1 cells
por: Xu, Xiaowen, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4ckne2lmod7nt8k2lsh19n6q1t